MDT Nov 2024 90.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.4100

+0.3000

(+14.22%)

At close: 02:31PM EDT

Loading interactive chart…

PR Newswire
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSelect™ Pulsed Field Ablation (PFA) System in treating atrial fibrillation (Afib). Invasive remapping conducted approximately two months post-ablation with the PulseSelect PFA System demonstrated durable isolation in 98% of pulmonary veins (PV) and 96% of patients had all veins isolated.
Zacks
Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Simply Wall St.
With 85% institutional ownership, Medtronic plc (NYSE:MDT) is a favorite amongst the big guns
Key Insights Significantly high institutional ownership implies Medtronic's stock price is sensitive to their trading...